Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 22, 1301-1308, December 1, 1962]
© 1962 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kimball, A. P.
Right arrow Articles by LePage, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kimball, A. P.
Right arrow Articles by LePage, G. A.

The Metabolism of 9-Butyl-6-thioguanine in Normal and Neoplastic Tissues*

A. P. Kimball and G. A. LePage

( Life Sciences Division, Stanford Research Institute, Menlo Park, California)

The metabolism of 9-butyl thioguanine (9-BTG)1 was studied in normal tissues and the Ehrlich ascites tumor with and without pretreatment with azaserine. The study of the distribution and metabolism of the drug was facilitated by the synthesis of 9-butyl-6-thioguanine-8-C14.

The results showed that 9-BTG was rapidly cleared from the blood, rapidly catabolized, and that the metabolites were rapidly excreted in the urine. Pretreatment with azaserine resulted in a longer retention of radioactivity in the acid-soluble fraction of the tissues.

Radioactivity was also found in the lipide fraction of the tissues. It was confirmed that 9-BTG was neither dealkylated nor incorporated into nucleic acids.

Treatment with toxic doses produced bone marrow depression with a terminal agranulocytosis.

* This work was supported in part by Contract No. SA-43-ph-3068 with the Cancer Chemotherapy National Service Center, National Cancer Institute, National Institutes of Health, and in part by grants from the United States Public Health Service (CY-4551) and the Gustavus and Louise Pfeiffer Research Foundation.

A preliminary report of this work has been made (Proc. Am. Assoc. Cancer Res., 3:333, 1962).

1 Abbreviations used: 9-BTG, 9-butyl-6-thioguanine; 9-BTG-8-C14, 9-butyl-6-thioguanine-8-C14; BW, water-saturated n-butanol; PA, n-propanol-1 M ammonium hydroxide (1:1); TCA, trichloroacetic acid.

Received 6/15/62.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1962 by the American Association for Cancer Research.